Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

ACTONEL

×

Overview

What is ACTONEL?

ACTONEL (risedronate sodium) tablets is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each ACTONEL tablet for oral administration contains the equivalent of 5, 30, 35, 75, or 150 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for risedronate sodium hemi-pentahydrate is CHNOPNa •2.5 HO. The chemical name of risedronate sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. The chemical structure of risedronate sodium hemi-pentahydrate is the following:

Risedronate sodium is a fine, white to off-white, odorless, crystalline powder. It is soluble in water and in aqueous solutions, and essentially insoluble in common organic solvents.

Inactive Ingredients

All dose strengths contain: crospovidone, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, silicon dioxide, titanium dioxide.

Dose strength-specific ingredients include: 5 mg—ferric oxide yellow, lactose monohydrate; 30 mg—lactose monohydrate; 35 mg—ferric oxide red, ferric oxide yellow, lactose monohydrate; 75 mg—ferric oxide red; 150 mg—FD&C blue #2 aluminum lake.



What does ACTONEL look like?



What are the available doses of ACTONEL?

Tablets: 5, 30, 35, 75, and 150 mg ()

What should I talk to my health care provider before I take ACTONEL?

ACTONEL is not recommended for use in patients with severe renal impairment (creatinine clearance <30 mL/min) (, , ).

ACTONEL is not indicated for use in pediatric patients ().

How should I use ACTONEL?

ACTONEL is indicated for the treatment and prevention of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis, ACTONEL reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [].

ACTONEL should be taken at least 30 minutes before the first food or drink of the day other than water.

To facilitate delivery to the stomach, ACTONEL should be swallowed while the patient is in an upright position and with a full glass of plain water (6 to 8 oz). Patients should not lie down for 30 minutes after taking the medication [ ].

Patients should receive supplemental calcium and vitamin D if dietary intake is inadequate [ ]. Calcium supplements and calcium-, aluminum-, and magnesium-containing medications may interfere with the absorption of ACTONEL and should be taken at a different time of the day. ACTONEL is not recommended for use in patients with severe renal impairment (creatinine clearance <30 mL/min). No dosage adjustment is necessary in patients with a creatinine clearance ≥30 mL/min or in the elderly.


What interacts with ACTONEL?

Sorry No Records found


What are the warnings of ACTONEL?

Sorry No Records found


What are the precautions of ACTONEL?

Sorry No Records found


What are the side effects of ACTONEL?

Sorry No records found


What should I look out for while using ACTONEL?

Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia (, )

Inability to stand or sit upright for at least 30 minutes (, )

Hypocalcemia (, )

Known hypersensitivity to any component of this product (, )


What might happen if I take too much ACTONEL?

Decreases in serum calcium and phosphorus following substantial overdose may be expected in some patients. Signs and symptoms of hypocalcemia may also occur in some of these patients. Milk or antacids containing calcium should be given to bind ACTONEL and reduce absorption of the drug.

In cases of substantial overdose, gastric lavage may be considered to remove unabsorbed drug. Standard procedures that are effective for treating hypocalcemia, including the administration of calcium intravenously, would be expected to restore physiologic amounts of ionized calcium and to relieve signs and symptoms of hypocalcemia.

Lethality after single oral doses was seen in female rats at 903 mg/kg and male rats at 1703 mg/kg. The minimum lethal dose in mice and rabbits was 4000 mg/kg and 1000 mg/kg, respectively. These values represent 320 to 620 times the 30 mg human dose based on surface area (mg/m).


How should I store and handle ACTONEL?

StorageStore Pantoprazole sodium delayed-release tablets at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.]StorageStore Pantoprazole sodium delayed-release tablets at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.]ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].ACTONEL is available as follows:5 mg film-coated, oval, yellow tablets with RSN on 1 face and 5 mg on the other.NDC 0149-0471-01 bottle of 30NDC 0149-0471-03 bottle of 200030 mg film-coated, oval, white tablets with RSN on 1 face and 30 mg on the other.NDC 0149-0470-01 bottle of 3035 mg film-coated, oval, orange tablets with RSN on 1 face and 35 mg on the other.NDC 0149-0472-01 dose pack of 4NDC 0149-0472-04 dose pack of 1275 mg film-coated, oval, pink tablets with RSN on 1 face and 75 mg on the other.NDC 0149-0477-01 dose pack of 2150 mg film-coated, oval, blue tablets with RSN on 1 face and 150 mg on the other.NDC 0149-0478-01 dose pack of 1NDC 0149-0478-03 dose pack of 3Store at controlled room temperature 20° to 25°C (68° to 77°F) [ USP].